Filing Flows

Filing Flows › 8-K events › Picard Medical

Picard Medical: departure or appointment of directors and officers

Form 8-K filed Nov 3, 2026 · items 5.02

What the filing says

On October 28, 2026, the Board of Directors (the “Board”) of Picard Medical, Inc., a Delaware company (the “Company”) appointed Richard Fang, Ph.D., as the Company’s Chief Executive Officer on a permanent, full-time basis, effective as of the same date. Fang has served as Interim Chief Executive Officer since June 18,

Read the filing on SEC EDGAR →

What usually followsAcross 39,174 8-Ks reporting Item 5.02 (directors and officers: departures, appointments, pay) in our universe, the stock's median move the next session was −0.1% (typical size ±1.4%, up 48% of the time); over the following 21 sessions, +0.7%. Every item ranked →

What this kind of filing means

Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.

Picard Medical at a glance

Latest quarterQ2 2026
Revenue$3.0M
Revenue Y/Y+39%
Operating margin-156.7%
IndustrySurgical & Medical Instruments & Apparatus

Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%. The chart follows the revenue to costs, profit and cash.

Picard Medical: every quarter, Q/Q and Y/Y, holders and guidance →

Picard Medical’s other material 8-Ks

Other recent ceo changes

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.